Form
20-F þ
|
Form
40-F o
|
Yes
o
|
No
þ
|
EXFO
ELECTRO-OPTICAL ENGINEERING INC.
|
|
By:
/s/ Germain
Lamonde
Name: Germain
Lamonde
Title: President
and Chief Executive Officer
|
|
§
|
Sales
increased 11.4% sequentially to US$39.2
million
|
§
|
Bookings
improved 19.9% sequentially to a record-high US$43.7
million
|
§
|
Six
new products launched, including NQMSfiber monitoring system for
optical networks
|
Segmented
results:
|
Q3
2007
|
Q3
2006
|
Q2
2007
|
|||||||||
(unaudited)
|
(unaudited)
|
(unaudited)
|
||||||||||
Sales:
|
||||||||||||
Telecom
Division
|
$ |
33,821
|
$ |
29,935
|
$ |
29,297
|
||||||
Life
Sciences and Industrial Division
|
5,384
|
5,475
|
5,910
|
|||||||||
Total
|
$ |
39,205
|
$ |
35,410
|
$ |
35,207
|
||||||
Earnings
(loss) from operations:
|
||||||||||||
Telecom
Division
|
$ |
2,143
|
$ |
3,696
|
$ |
1,078
|
||||||
Life
Sciences and Industrial Division
|
697
|
(88 | ) |
1,003
|
||||||||
Total
|
$ |
2,840
|
$ |
3,608
|
$ |
2,081
|
||||||
Other
selected information:
|
||||||||||||
GAAP
net earnings
|
$ |
2,574
|
$ |
3,504
|
$ |
2,684
|
||||||
Amortization
of intangible assets
|
$ |
653
|
$ |
994
|
$ |
630
|
||||||
Stock-based
compensation costs
|
$ |
178
|
$ |
264
|
$ |
241
|
||||||
Impairment
of long-lived assets
|
$ |
―
|
$ |
604
|
$ |
―
|
||||||
Grants
revenue
|
$ |
―
|
$ |
1,307
|
$ |
―
|
As
at
May
31,
2007
|
As
at
August
31,
2006
|
|||||||
(unaudited)
|
||||||||
Assets
|
||||||||
Current
assets
|
||||||||
Cash
|
$ |
6,008
|
$ |
6,853
|
||||
Short-term
investments
|
116,466
|
104,437
|
||||||
Accounts
receivable
|
||||||||
Trade,
less allowance for doubtful accounts of $265
($451
as at August 31, 2006)
|
27,240
|
20,891
|
||||||
Other
|
2,293
|
2,792
|
||||||
Income
taxes and tax credits recoverable
|
4,264
|
2,201
|
||||||
Inventories
(note 6)
|
28,325
|
24,623
|
||||||
Prepaid
expenses
|
1,545
|
1,404
|
||||||
186,141
|
163,201
|
|||||||
Income
taxes recoverable
|
−
|
476
|
||||||
Property,
plant and equipment
|
17,239
|
17,392
|
||||||
Intangible
assets
|
9,844
|
10,948
|
||||||
Goodwill
|
28,078
|
27,142
|
||||||
$ |
241,302
|
$ |
219,159
|
|||||
Liabilities
|
||||||||
Current
liabilities
|
||||||||
Accounts
payable and accrued liabilities (note 7)
|
$ |
20,792
|
$ |
17,337
|
||||
Deferred
revenue
|
2,363
|
1,772
|
||||||
Current
portion of long-term debt
|
107
|
107
|
||||||
23,262
|
19,216
|
|||||||
Deferred
revenue
|
3,438
|
2,632
|
||||||
Government
grants
|
723
|
723
|
||||||
Long-term
debt
|
287
|
354
|
||||||
27,710
|
22,925
|
|||||||
Contingency
(note 8)
|
||||||||
Shareholders’
Equity
|
||||||||
Share
capital
|
149,715
|
148,921
|
||||||
Contributed
surplus
|
4,242
|
3,776
|
||||||
Retained
earnings (note 9)
|
8,791
|
−
|
||||||
Cumulative
translation adjustment
|
50,844
|
43,537
|
||||||
213,592
|
196,234
|
|||||||
$ |
241,302
|
$ |
219,159
|
Three
months ended
May
31, 2007
|
Nine
months ended
May
31, 2007
|
Three
months ended
May
31, 2006
|
Nine
months ended
May
31, 2006
|
|||||||||||||
Sales
|
$ |
39,205
|
$ |
109,959
|
$ |
35,410
|
$ |
92,520
|
||||||||
Cost
of sales (1,2)
|
16,828
|
47,027
|
15,453
|
40,957
|
||||||||||||
Gross
margin
|
22,377
|
62,932
|
19,957
|
51,563
|
||||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative (1)
|
12,819
|
36,545
|
11,080
|
29,441
|
||||||||||||
Net
research and development (1)
(note 10)
|
5,328
|
14,360
|
4,095
|
11,123
|
||||||||||||
Amortization
of property, plant and equipment
|
737
|
2,182
|
883
|
2,652
|
||||||||||||
Amortization
of intangible assets
|
653
|
2,165
|
994
|
3,351
|
||||||||||||
Impairment
of long-lived assets (note 4)
|
−
|
−
|
604
|
604
|
||||||||||||
Government
grants (note 5)
|
−
|
−
|
(1,307 | ) | (1,307 | ) | ||||||||||
Total
operating expenses
|
19,537
|
55,252
|
16,349
|
45,864
|
||||||||||||
Earnings
from operations
|
2,840
|
7,680
|
3,608
|
5,699
|
||||||||||||
Interest
and other income
|
1,236
|
3,513
|
796
|
2,179
|
||||||||||||
Foreign
exchange gain (loss)
|
(628 | ) |
107
|
(81 | ) | (612 | ) | |||||||||
Earnings
before income taxes
|
3,448
|
11,300
|
4,323
|
7,266
|
||||||||||||
Income
taxes (note 11)
|
874
|
2,509
|
819
|
2,041
|
||||||||||||
Net
earnings for the period
|
$ |
2,574
|
$ |
8,791
|
$ |
3,504
|
$ |
5,225
|
||||||||
Basic
and diluted net earnings per share
|
$ |
0.04
|
$ |
0.13
|
$ |
0.05
|
$ |
0.08
|
||||||||
Basic
weighted average number of shares outstanding
(000’s)
|
68,917
|
68,844
|
68,676
|
68,613
|
||||||||||||
Diluted
weighted average number of shares outstanding
(000’s)
(note
12)
|
69,590
|
69,507
|
69,543
|
69,252
|
||||||||||||
(1)
Stock-based compensation costs included
in:
|
||||||||||||||||
Cost
of sales
|
$ |
32
|
$ |
93
|
$ |
39
|
$ |
111
|
||||||||
Selling
and administrative
|
86
|
442
|
180
|
559
|
||||||||||||
Net
research and development
|
60
|
169
|
45
|
149
|
||||||||||||
$ |
178
|
$ |
704
|
$ |
264
|
$ |
819
|
Retained
earnings (Deficit)
|
||||||||
Nine
months ended
May
31,
|
||||||||
2007
|
2006
|
|||||||
Balance
– Beginning of period (note 9)
|
$ |
−
|
$ | (381,846 | ) | |||
Add
|
||||||||
Net
earnings for the period
|
8,791
|
5,225
|
||||||
Balance
– End of period
|
$ |
8,791
|
$ | (376,621 | ) |
Contributed
surplus
|
||||||||
Nine
months ended
May
31,
|
||||||||
2007
|
2006
|
|||||||
Balance
– Beginning of period
|
$ |
3,776
|
$ |
2,949
|
||||
Add
(deduct)
|
||||||||
Stock-based
compensation costs
|
687
|
797
|
||||||
Reclassification
of stock-based compensation costs to share capital upon exercise
of stock
awards
|
(221 | ) | (172 | ) | ||||
Balance
– End of period
|
$ |
4,242
|
$ |
3,574
|
Three
months ended
May
31, 2007
|
Nine
months ended
May
31, 2007
|
Three
months ended
May
31, 2006
|
Nine
months ended
May
31, 2006
|
|||||||||||||
Cash
flows from operating activities
|
||||||||||||||||
Net
earnings for the period
|
$ |
2,574
|
$ |
8,791
|
$ |
3,504
|
$ |
5,225
|
||||||||
Add
(deduct) items not affecting cash
|
||||||||||||||||
Discount
on short-term investments
|
(190 | ) |
588
|
(98 | ) |
520
|
||||||||||
Stock-based
compensation costs
|
178
|
704
|
264
|
819
|
||||||||||||
Amortization
|
1,390
|
4,347
|
1,877
|
6,003
|
||||||||||||
Unrealized
losses on short-term investments
|
70
|
70
|
123
|
123
|
||||||||||||
Impairment
of long-lived assets
|
−
|
−
|
604
|
604
|
||||||||||||
Gain
on disposal of property, plant and equipment
|
(100 | ) | (100 | ) |
−
|
−
|
||||||||||
Deferred
revenue
|
(75 | ) |
1,164
|
148
|
248
|
|||||||||||
Government
grants
|
−
|
(22 | ) | (1,307 | ) | (1,307 | ) | |||||||||
3,847
|
15,542
|
5,115
|
12,235
|
|||||||||||||
Change
in non-cash operating items
|
||||||||||||||||
Accounts
receivable
|
(3,015 | ) | (6,260 | ) | (5,085 | ) | (4,158 | ) | ||||||||
Income
taxes and tax credits
|
(466 | ) | (1,397 | ) | (612 | ) | (1,361 | ) | ||||||||
Inventories
|
(2,503 | ) | (2,632 | ) | (182 | ) | (3,090 | ) | ||||||||
Prepaid
expenses
|
(224 | ) | (89 | ) | (153 | ) | (181 | ) | ||||||||
Accounts
payable and accrued liabilities
|
(231 | ) |
2,541
|
(1,357 | ) |
615
|
||||||||||
(2,592 | ) |
7,705
|
(2,274 | ) |
4,060
|
|||||||||||
Cash
flows from investing activities
|
||||||||||||||||
Additions
to short-term investments
|
(236,286 | ) | (726,789 | ) | (227,589 | ) | (638,634 | ) | ||||||||
Proceeds
from disposal and maturity of short-term
investments
|
235,446
|
718,362
|
230,756
|
651,655
|
||||||||||||
Additions
to property, plant and equipment and intangible assets
|
(1,890 | ) | (3,536 | ) | (963 | ) | (2,531 | ) | ||||||||
Net
proceeds from disposal of property, plant and equipment
|
1,563
|
2,791
|
−
|
−
|
||||||||||||
Business
combination (note 3)
|
−
|
−
|
(219 | ) | (17,716 | ) | ||||||||||
(1,167 | ) | (9,172 | ) |
1,985
|
(7,226 | ) | ||||||||||
Cash
flows from financing activities
|
||||||||||||||||
Repayment
of long-term debt
|
(27 | ) | (78 | ) | (84 | ) | (158 | ) | ||||||||
Exercise
of stock options
|
90
|
573
|
347
|
503
|
||||||||||||
63
|
495
|
263
|
345
|
|||||||||||||
Effect
of foreign exchange rate changes on cash
|
596
|
127
|
230
|
683
|
||||||||||||
Change
in cash
|
(3,100 | ) | (845 | ) |
204
|
(2,138 | ) | |||||||||
Cash
– Beginning of period
|
9,108
|
6,853
|
4,777
|
7,119
|
||||||||||||
Cash
– End of period
|
$ |
6,008
|
$ |
6,008
|
$ |
4,981
|
$ |
4,981
|
1.
|
Interim
financial information
|
2.
|
New
accounting standards and
pronouncements
|
3.
|
Business
Combination
|
Assets
acquired
|
||||
Current
assets
|
$ |
5,135
|
||
Property,
plant and equipment
|
3,115
|
|||
Core
technology
|
8,709
|
|||
Current
liabilities assumed
|
(2,826 | ) | ||
Loans
assumed
|
(402 | ) | ||
Net
identifiable assets acquired
|
13,731
|
|||
Goodwill
|
5,107
|
|||
Purchase
price, net of cash acquired
|
$ |
18,838
|
6.
|
Inventories
|
As
at
May
31,
2007
|
As
at
August
31,
2006
|
|||||||
(unaudited)
|
||||||||
Raw
materials
|
$ |
14,687
|
$ |
14,353
|
||||
Work
in progress
|
1,930
|
1,043
|
||||||
Finished
goods
|
11,708
|
9,227
|
||||||
$ |
28,325
|
$ |
24,623
|
7.
|
Accounts
payable and accrued
liabilities
|
As
at
May
31,
2007
|
As
at
August
31,
2006
|
|||||||
(unaudited)
|
||||||||
Trade
|
$ |
10,733
|
$ |
7,487
|
||||
Salaries
and social benefits
|
6,678
|
5,991
|
||||||
Warranty
|
855
|
1,006
|
||||||
Commissions
|
847
|
835
|
||||||
Restructuring
charges
|
−
|
691
|
||||||
Other
|
1,679
|
1,327
|
||||||
$ |
20,792
|
$ |
17,337
|
Nine
months ended
May
31,
|
||||||||
2007
|
2006
|
|||||||
(unaudited)
|
||||||||
Balance
- Beginning of
period
|
$ |
1,006
|
$ |
725
|
||||
Provision
|
597
|
717
|
||||||
Settlements
|
(748 | ) | (569 | ) | ||||
Addition
from business combination
|
−
|
31
|
||||||
Balance
- End of
period
|
$ |
855
|
$ |
904
|
Balance
as at
August
31,
2006
|
Payments
|
Balance
as at
May
31,
2007
|
||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||
Fiscal
2006 plan
|
||||||||||||
Severance
expenses
|
$ |
631
|
$ | (631 | ) | $ |
−
|
|||||
Fiscal
2003 plan
|
||||||||||||
Exited
leased facilities
|
60
|
(60 | ) |
−
|
||||||||
Total
for all plans
|
$ |
691
|
$ | (691 | ) | $ |
−
|
8.
|
Contingency
|
9.
|
Elimination
of deficit
|
10.
|
Net
research and development
expenses
|
Three
months ended
May
31, 2007
|
Nine
months ended
May
31, 2007
|
Three
months ended
May
31, 2006
|
Nine
months ended
May
31, 2006
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Gross
research and development expenses
|
$ |
6,637
|
$ |
18,085
|
$ |
5,339
|
$ |
14,285
|
||||||||
Research
and development tax credits and grants
|
(1,309 | ) | (3,725 | ) | (1,244 | ) | (3,162 | ) | ||||||||
$ |
5,328
|
$ |
14,360
|
$ |
4,095
|
$ |
11,123
|
11.
|
Income
taxes
|
12.
|
Earnings
per share
|
Three
months
ended
May
31, 2007
|
Nine
months
ended
May
31, 2007
|
Three
months
ended
May
31, 2006
|
Nine
months
ended
May
31, 2006
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Basic
weighted average number of shares outstanding (000’s)
|
68,917
|
68,844
|
68,676
|
68,613
|
||||||||||||
Plus
dilutive effect of:
|
||||||||||||||||
Stock
options (000’s)
|
435
|
446
|
664
|
519
|
||||||||||||
Restricted
share units (000’s)
|
184
|
168
|
169
|
91
|
||||||||||||
Deferred
share units (000’s)
|
54
|
49
|
34
|
29
|
||||||||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,590
|
69,507
|
69,543
|
69,252
|
||||||||||||
Stock
awards excluded from the calculation of diluted weighted average
number of
shares outstanding because their exercise price was greater than
the
average market price of the common shares (000’s)
|
1,132
|
1,255
|
1,318
|
1,229
|
13.
|
Segment
information
|
Three
months ended May 31, 2007
|
Nine
months ended May 31, 2007
|
|||||||||||||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
|||||||||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||||||||||
Sales
|
$ |
33,821
|
$ |
5,384
|
$ |
39,205
|
$ |
92,640
|
$ |
17,319
|
$ |
109,959
|
||||||||||||
Earnings
from operations
|
$ |
2,143
|
$ |
697
|
$ |
2,840
|
$ |
5,024
|
$ |
2,656
|
$ |
7,680
|
||||||||||||
Unallocated
items:
|
||||||||||||||||||||||||
Interest
and other income
|
1,236
|
3,513
|
||||||||||||||||||||||
Foreign
exchange gain (loss)
|
(628 | ) |
107
|
|||||||||||||||||||||
Earnings before income taxes
|
3,448
|
11,300
|
||||||||||||||||||||||
Income
taxes
|
874
|
2,509
|
||||||||||||||||||||||
Net
earnings for the period
|
$ |
2,574
|
$ |
8,791
|
Three
months ended May 31, 2006
|
Nine
months ended May 31, 2006
|
|||||||||||||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
|||||||||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||||||||||
Sales
|
$ |
29,935
|
$ |
5,475
|
$ |
35,410
|
$ |
77,265
|
$ |
15,255
|
$ |
92,520
|
||||||||||||
Earnings (loss) from operations
|
$ |
3,696
|
$ | (88 | ) | $ |
3,608
|
$ |
5,404
|
$ |
295
|
$ |
5,699
|
|||||||||||
Unallocated
items:
|
||||||||||||||||||||||||
Interest
income
|
796
|
2,179
|
||||||||||||||||||||||
Foreign
exchange loss
|
(81 | ) | (612 | ) | ||||||||||||||||||||
Earnings before income taxes
|
4,323
|
7,266
|
||||||||||||||||||||||
Income
taxes
|
819
|
2,041
|
||||||||||||||||||||||
Net
earnings for the period
|
$ |
3,504
|
$ |
5,225
|
As
at
May
31,
2007
|
As
at
August
31,
2006
|
|||||||
(unaudited)
|
||||||||
Total
assets
|
||||||||
Telecom
Division
|
$ |
104,668
|
$ |
93,853
|
||||
Life
Sciences and Industrial Division
|
9,896
|
11,339
|
||||||
Unallocated
assets
|
126,738
|
113,967
|
||||||
$ |
241,302
|
$ |
219,159
|
14.
|
Stock-based
compensation
|
15.
|
Differences
between Canadian and U.S.
GAAP
|
Three
months ended
May
31, 2007
|
Nine
months ended
May
31, 2007
|
Three
months ended
May
31, 2006
|
Nine
months ended
May
31, 2006
|
|||||||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||||||
Net
earnings for the period in accordance with Canadian GAAP
|
$ |
2,574
|
$ |
8,791
|
$ |
3,504
|
$ |
5,225
|
||||||||||||
Unrealized
losses on available-for-sale securities
|
a | ) |
70
|
70
|
123
|
123
|
||||||||||||||
Net
earnings for the period in accordance with U.S. GAAP
|
2,644
|
8,861
|
3,627
|
5,348
|
||||||||||||||||
Other
comprehensive income (loss)
|
||||||||||||||||||||
Foreign
currency translation adjustment
|
16,942
|
6,638
|
5,646
|
12,957
|
||||||||||||||||
Unrealized
gains (losses) on forward exchange contracts
|
4,262
|
(1,531 | ) |
2,002
|
4,798
|
|||||||||||||||
Reclassification
in net earnings of realized losses (gains) on forward exchange
contracts
|
40
|
(804 | ) | (807 | ) | (1,824 | ) | |||||||||||||
Unrealized
losses on available-for-sale securities
|
a | ) | (70 | ) | (70 | ) | (123 | ) | (123 | ) | ||||||||||
Comprehensive
income
|
$ |
23,818
|
$ |
13,094
|
$ |
10,345
|
$ |
21,156
|
||||||||||||
Basic
and diluted net earnings per share in accordance with U.S.
GAAP
|
$ |
0.04
|
$ |
0.13
|
$ |
0.05
|
$ |
0.08
|
||||||||||||
Basic
weighted average number of shares outstanding (000’s)
|
68,917
|
68,844
|
68,676
|
68,613
|
||||||||||||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,590
|
69,507
|
69,543
|
69,252
|
As
at
May
31,
2007
|
As
at
August
31,
2006
|
|||||||
(unaudited)
|
||||||||
Shareholders’
equity in accordance with Canadian GAAP
|
$ |
213,592
|
$ |
196,234
|
||||
Forward
exchange contracts
|
3,116
|
5,451
|
||||||
Goodwill
|
(12,536 | ) | (11,908 | ) | ||||
Shareholders’
equity in accordance with U.S. GAAP
|
$ |
204,172
|
$ |
189,777
|
Share
capital
|
Contributed
surplus
|
Deficit
|
Deferred
stock-based
compensation costs
|
Other
capital
|
Accumulated
other comprehensive income
|
Shareholders’
equity
|
||||||||||||||||||||||
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
||||||||||||||||||||||
Balance
as at August 31, 2006
|
$ |
598,421
|
$ |
1,537
|
$ | (458,944 | ) | $ | (1,371 | ) | $ |
5,504
|
$ |
44,630
|
$ |
189,777
|
||||||||||||
Net
earnings for the period
|
–
|
–
|
3,533
|
–
|
–
|
–
|
3,533
|
|||||||||||||||||||||
Stock-based
compensation costs
|
–
|
–
|
–
|
(347 | ) |
593
|
–
|
246
|
||||||||||||||||||||
Foreign
currency translation adjustment
|
–
|
–
|
–
|
–
|
–
|
(5,832 | ) | (5,832 | ) | |||||||||||||||||||
Unrealized
losses on forward exchange contracts
|
–
|
–
|
–
|
–
|
–
|
(2,811 | ) | (2,811 | ) | |||||||||||||||||||
Exercise
of stock options
|
121
|
–
|
–
|
–
|
–
|
–
|
121
|
|||||||||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock
awards
|
47
|
–
|
–
|
–
|
(47 | ) |
–
|
–
|
||||||||||||||||||||
Balance
as at November 30, 2006
|
$ |
598,589
|
$ |
1,537
|
$ | (455,411 | ) | $ | (1,718 | ) | $ |
6,050
|
$ |
35,987
|
$ |
185,034
|
||||||||||||
Net
earnings for the period
|
–
|
–
|
2,684
|
–
|
–
|
–
|
2,684
|
|||||||||||||||||||||
Stock-based
compensation costs
|
–
|
–
|
–
|
(510 | ) |
750
|
–
|
240
|
||||||||||||||||||||
Foreign
currency translation adjustment
|
–
|
–
|
–
|
–
|
–
|
(4,472 | ) | (4,472 | ) | |||||||||||||||||||
Unrealized
losses on forward exchange contracts
|
–
|
–
|
–
|
–
|
–
|
(3,826 | ) | (3,826 | ) | |||||||||||||||||||
Exercise
of stock options
|
362
|
–
|
–
|
–
|
–
|
–
|
362
|
|||||||||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock
awards
|
127
|
–
|
–
|
–
|
(127 | ) |
–
|
–
|
||||||||||||||||||||
Balance
as at February 28, 2007
|
$ |
599,078
|
$ |
1,537
|
$ | (452,727 | ) | $ | (2,228 | ) | $ |
6,673
|
$ |
27,689
|
$ |
180,022
|
||||||||||||
Net
earnings for the period
|
–
|
–
|
2,644
|
–
|
–
|
–
|
2,644
|
|||||||||||||||||||||
Stock-based
compensation costs
|
–
|
–
|
–
|
372
|
(130 | ) |
–
|
242
|
||||||||||||||||||||
Foreign
currency translation adjustment
|
–
|
–
|
–
|
–
|
–
|
16,942
|
16,942
|
|||||||||||||||||||||
Unrealized
gains on forward exchange contracts
|
–
|
–
|
–
|
–
|
–
|
4,302
|
4,302
|
|||||||||||||||||||||
Unrealized
losses on available-for-sale securities
|
–
|
–
|
–
|
–
|
–
|
(70 | ) | (70 | ) | |||||||||||||||||||
Exercise
of stock options
|
90
|
–
|
–
|
–
|
–
|
–
|
90
|
|||||||||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock
awards
|
47
|
–
|
–
|
–
|
(47 | ) |
–
|
–
|
||||||||||||||||||||
Balance
as at May 31, 2007
|
$ |
599,215
|
$ |
1,537
|
$ | (450,083 | ) | $ | (1,856 | ) | $ |
6,496
|
$ |
48,863
|
$ |
204,172
|
As
at
May
31,
2007
|
As
at
August
31,
2006
|
|||||||
(unaudited)
|
||||||||
Foreign
currency translation adjustment
|
||||||||
Current
period
|
$ |
6,638
|
$ |
12,322
|
||||
Cumulative
effect of prior periods
|
39,179
|
26,857
|
||||||
45,817
|
39,179
|
|||||||
Unrealized
gains (losses) on forward exchange contracts
|
||||||||
Current
period
|
(2,335 | ) |
2,514
|
|||||
Cumulative
effect of prior periods
|
5,451
|
2,937
|
||||||
3,116
|
5,451
|
|||||||
Unrealized
losses on available-for-sale securities
|
||||||||
Cumulative
effect of prior periods
|
(70 | ) |
−
|
|||||
$ |
48,863
|
$ |
44,630
|
Three
months ended
May
31, 2007
|
Three
months ended
May
31, 2006
|
Nine
months ended
May
31, 2007
|
Nine
months ended
May
31, 2006
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Sales
|
$ |
39,205
|
$ |
35,410
|
$ |
109,959
|
$ |
92,520
|
||||||||
Cost
of sales (1)
|
16,828
|
15,453
|
47,027
|
40,957
|
||||||||||||
Gross
margin
|
22,377
|
19,957
|
62,932
|
51,563
|
||||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative
|
12,819
|
11,080
|
36,545
|
29,441
|
||||||||||||
Net
research and development
|
5,328
|
4,095
|
14,360
|
11,123
|
||||||||||||
Amortization
of property, plant and equipment
|
737
|
883
|
2,182
|
2,652
|
||||||||||||
Amortization
of intangible assets
|
653
|
994
|
2,165
|
3,351
|
||||||||||||
Impairment
of long-lived assets
|
−
|
604
|
−
|
604
|
||||||||||||
Government
grants
|
−
|
(1,307 | ) |
−
|
(1,307 | ) | ||||||||||
Total
operating expenses
|
19,537
|
16,349
|
55,252
|
45,864
|
||||||||||||
Earnings
from operations
|
2,840
|
3,608
|
7,680
|
5,699
|
||||||||||||
Interest and
other income
|
1,236
|
796
|
3,513
|
2,179
|
||||||||||||
Foreign
exchange gain (loss)
|
(628 | ) | (81 | ) |
107
|
(612 | ) | |||||||||
Earnings
before income taxes
|
3,448
|
4,323
|
11,300
|
7,266
|
||||||||||||
Income
taxes
|
874
|
819
|
2,509
|
2,041
|
||||||||||||
Net
earnings for the period
|
$ |
2,574
|
$ |
3,504
|
$ |
8,791
|
$ |
5,225
|
||||||||
Basic
and diluted net earnings per share
|
$ |
0.04
|
$ |
0.05
|
$ |
0.13
|
$ |
0.08
|
||||||||
Segment
information:
|
||||||||||||||||
Sales:
|
||||||||||||||||
Telecom
Division
|
$ |
33,821
|
$ |
29,935
|
$ |
92,640
|
$ |
77,265
|
||||||||
Life
Sciences and Industrial Division
|
5,384
|
5,475
|
17,319
|
15,255
|
||||||||||||
$ |
39,205
|
$ |
35,410
|
$ |
109,959
|
$ |
92,520
|
|||||||||
Earnings
(loss) from operations:
|
||||||||||||||||
Telecom
Division
|
$ |
2,143
|
$ |
3,696
|
$ |
5,024
|
$ |
5,404
|
||||||||
Life
Sciences and Industrial Division
|
697
|
(88 | ) |
2,656
|
295
|
|||||||||||
$ |
2,840
|
$ |
3,608
|
$ |
7,680
|
$ |
5,699
|
|||||||||
Research
and development data:
|
||||||||||||||||
Gross
research and development
|
$ |
6,637
|
$ |
5,339
|
$ |
18,085
|
$ |
14,285
|
||||||||
Net
research and development
|
$ |
5,328
|
$ |
4,095
|
$ |
14,360
|
$ |
11,123
|
||||||||
Three
months ended
May
31, 2007
|
Three
months ended
May
31, 2006
|
Nine
months ended
May
31, 2007
|
Nine
months ended
May
31, 2006
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Sales
|
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||
Cost
of sales (1)
|
42.9
|
43.6
|
42.8
|
44.3
|
||||||||||||
Gross
margin
|
57.1
|
56.4
|
57.2
|
55.7
|
||||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative
|
32.7
|
31.3
|
33.2
|
31.8
|
||||||||||||
Net
research and development
|
13.6
|
11.6
|
13.0
|
12.0
|
||||||||||||
Amortization
of property, plant and equipment
|
1.9
|
2.5
|
2.0
|
2.8
|
||||||||||||
Amortization
of intangible assets
|
1.7
|
2.8
|
2.0
|
3.6
|
||||||||||||
Impairment
of long-lived assets
|
−
|
1.7
|
−
|
0.7
|
||||||||||||
Government
grants
|
−
|
(3.7 | ) |
−
|
(1.4 | ) | ||||||||||
Total
operating expenses
|
49.9
|
46.2
|
50.2
|
49.5
|
||||||||||||
Earnings
from operations
|
7.2
|
10.2
|
7.0
|
6.2
|
||||||||||||
Interest
and other income
|
3.2
|
2.2
|
3.2
|
2.4
|
||||||||||||
Foreign
exchange gain (loss)
|
(1.6 | ) | (0.2 | ) |
0.1
|
(0.7 | ) | |||||||||
Earnings
before income taxes
|
8.8
|
12.2
|
10.3
|
7.9
|
||||||||||||
Income
taxes
|
2.2
|
2.3
|
2.3
|
2.2
|
||||||||||||
Net
earnings for the period
|
6.6 | % | 9.9 | % | 8.0 | % | 5.7 | % | ||||||||
Segment
information:
|
||||||||||||||||
Sales:
|
||||||||||||||||
Telecom
Division
|
86.3 | % | 84.5 | % | 84.2 | % | 83.5 | % | ||||||||
Life
Sciences and Industrial Division
|
13.7
|
15.5
|
15.8
|
16.5
|
||||||||||||
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||
Earnings
(loss) from operations:
|
||||||||||||||||
Telecom
Division
|
5.5 | % | 10.4 | % | 4.6 | % | 5.8 | % | ||||||||
Life
Sciences and Industrial Division
|
1.7
|
(0.2 | ) |
2.4
|
0.4
|
|||||||||||
7.2 | % | 10.2 | % | 7.0 | % | 6.2 | % | |||||||||
Research
and development data:
|
||||||||||||||||
Gross
research and development
|
16.9 | % | 15.1 | % | 16.4 | % | 15.4 | % | ||||||||
Net
research and development
|
13.6 | % | 11.6 | % | 13.0 | % | 12.0 | % | ||||||||
Expiry
dates
|
Contractual
amounts
|
Weighted
average contractual forward rates
|
||
June
2007 to August 2007
|
$10,800,000
|
1.1499
|
||
September
2007 to December 2009
|
$48,300,000
|
1.1312
|
Stock
Options
|
Number
|
%
of issued and outstanding
|
Weighted
average exercise price
|
|||
Chairman
of the Board, President and CEO
(one
individual)
|
179,642
|
9%
|
$ 9.05
|
|||
Board
of Directors (five individuals)
|
194,375
|
9%
|
$ 6.23
|
|||
Management
and Corporate Officers (eight individuals)
|
236,319
|
12%
|
$13.25
|
|||
610,336
|
30%
|
$ 9.78
|
Restricted
Share Units (RSUs)
|
Number
|
%
of issued and outstanding
|
||||
Chairman
of the Board, President and CEO
(one
individual)
|
59,913
|
12%
|
||||
Management
and Corporate Officers
(ten
individuals)
|
236,185
|
48%
|
||||
296,098
|
60%
|
Deferred
Share Units (DSUs)
|
Number
|
%
of issued and outstanding
|
||||
Board
of Directors (five individuals)
|
64,718
|
100%
|
Q3-FY07
|
Q2-FY07
|
Q1-FY07
|
Q4-FY06
|
|||||||||||||
Sales
|
$ |
39,205
|
$ |
35,207
|
$ |
35,547
|
$ |
35,733
|
||||||||
Cost
of sales
|
$ |
16,828
|
$ |
14,970
|
$ |
15,229
|
$ |
16,318
|
||||||||
Gross
margin
|
$ |
22,377
|
$ |
20,237
|
$ |
20,318
|
$ |
19,415
|
||||||||
Earnings
from operations
|
$ |
2,840
|
$ |
2,081
|
$ |
2,759
|
$ |
2,363
|
||||||||
Net
earnings
|
$ |
2,574
|
$ |
2,684
|
$ |
3,533
|
$ |
2,910
|
||||||||
Basic
and diluted net earnings per share
|
$ |
0.04
|
$ |
0.04
|
$ |
0.05
|
$ |
0.04
|
Q3-FY06
|
Q2-FY06
|
Q1-FY06
|
Q4-FY05
|
|||||||||||||
Sales
|
$ |
35,410
|
$ |
30,066
|
$ |
27,044
|
$ |
26,304
|
||||||||
Cost
of sales
|
$ |
15,453
|
$ |
13,440
|
$ |
12,064
|
$ |
11,925
|
||||||||
Gross
margin
|
$ |
19,957
|
$ |
16,626
|
$ |
14,980
|
$ |
14,379
|
||||||||
Earnings
from operations
|
$ |
3,608
|
$ |
1,408
|
$ |
683
|
$ |
811
|
||||||||
Net
earnings
|
$ |
3,504
|
$ |
1,366
|
$ |
355
|
$ |
454
|
||||||||
Basic
and diluted net earnings per share
|
$ |
0.05
|
$ |
0.02
|
$ |
0.01
|
$ |
0.01
|